OA
AGN

Oak Associates’s Allergan plc AGN Stock Holding History

Oak Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,200
Closed -$1.1M – 141
2020
Q1 		$1.1M Sell
6,200
-2,300
-27% -$433K 0.09% 87
2019
Q4 		$1.63M Hold
8,500
– – 0.1% 91
2019
Q3 		$1.43M Hold
8,500
– – 0.09% 90
2019
Q2 		$1.42M Hold
8,500
– – 0.09% 92
2019
Q1 		$1.24M Hold
8,500
– – 0.08% 101
2018
Q4 		$1.14M Buy
+8,500
New +$1.39M 0.08% 96

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Oak Associates's AGN Position: Q2 2020 in Review

Oak Associates sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,200 shares — an estimated $1.1M sold.

Oak Associates first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $1.63M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Oak Associates reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Oak Associates sold 6,200 Allergan plc shares in Q2 2020, an estimated $1.1M.
  • Oak Associates first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Oak Associates's Allergan plc position peaked at $1.63M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Oak Associates's 13F filing for Q2 2020, filed 11 Aug 2020.